Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 2.0 | 5.0 |
Min SIP Amount | ₹500 | ₹500 |
Expense Ratio | 2.25 | 1.71 |
NAV | ₹22.51 | ₹350.65 |
Fund Started | 17 Dec 2018 | 08 Mar 2000 |
Fund Size | ₹53.51 Cr | ₹10799.00 Cr |
Exit Load | - | - |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 19.38% | 14.50% |
3 Year | 15.15% | 18.72% |
5 Year | 15.01% | 30.12% |
1 Year
3 Year
5 Year
Equity | 93.76% | 96.62% |
Cash | 6.15% | 3.39% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Sun Pharmaceutical Industries Ltd. | 3.30% |
Trent Ltd. | 3.15% |
Bharti Airtel Ltd. | 2.98% |
Bosch Ltd. | 2.74% |
Lupin Ltd. | 2.57% |
Torrent Pharmaceuticals Ltd. | 2.48% |
ICICI Bank Ltd. | 2.36% |
Glenmark Pharmaceuticals Ltd. | 2.34% |
HCL Technologies Ltd. | 2.31% |
Divi's Laboratories Ltd. | 2.31% |
Name | Assets |
---|---|
Reliance Industries Ltd. | 9.55% |
JIO Financial Services Ltd. | 8.05% |
Samvardhana Motherson International Ltd. | 7.54% |
Adani Power Ltd. | 7.24% |
Life Insurance Corporation of India | 6.27% |
Larsen & Toubro Ltd. | 5.80% |
Grasim Industries Ltd. | 5.73% |
Aurobindo Pharma Ltd. | 4.93% |
Divi's Laboratories Ltd. | 4.18% |
NTPC Ltd. | 4.15% |
Name | Gargi Bhattacharyya Banerjee | Ankit A Pande |
Start Date | 21 Nov 2019 | 22 Aug 2023 |
Name
Start Date
Description | The Scheme seeks to generate income and long-term capital appreciation from a diversified portfolio of predominantly equity and equity related securities and enable investors to avail the income tax rebate, as permitted from time to time. | The scheme aims to generate capital appreciation by investing predominantly in equity shares with growth potential. The secondary objective is to give dividend and other income. |
Launch Date | 17 Dec 2018 | 08 Mar 2000 |
Description
Launch Date